XOMAP Q2 2021 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$901,000+102.9% YoY

Gross Profit

$863,00095.8% margin

Operating Income

-$3M-340.1% margin

Net Income

-$2M-248.3% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

+140.3%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$4M

Stock-Based Comp.

$768,000

Balance Sheet

Total Assets

$136M

Total Liabilities

$19M

Stockholders' Equity

$117M

Cash & Equivalents

$79M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$901,000	$444,000	+102.9%
Gross Profit	$863,000	$406,000	+112.6%
Operating Income	-$3M	-$3M	+2.8%
Net Income	-$2M	-$4M	+36.7%